Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.

Saved in:
Bibliographic Details
Title: Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.
Authors: Fernández Montes A; University Hospital of Ourense, Ourense, Spain., Martínez Lago N; University Hospital of A Coruña, A Coruña, Spain., Covela Rúa M; Universital Hospital Lucus Augusti, Lugo, Spain., de la Cámara Gómez J; University Hospital Arquitecto Marcide, Ferrol, Spain., González Villaroel P; Oncological Center of Galicia, A Coruña, Spain., Méndez Méndez JC; Univerity Hospital Álvaro Cunqueiro, Vigo, Spain., Jorge Fernández M; University Hospital Arquitecto Marcide, Ferrol, Spain., Salgado Fernández M; University Hospital of Ourense, Ourense, Spain., Reboredo López M; University Hospital of A Coruña, A Coruña, Spain., Quintero Aldana G; Universital Hospital Lucus Augusti, Lugo, Spain., Luz Pellón Augusto M; University Hospital Arquitecto Marcide, Ferrol, Spain., Graña Suárez B; University Hospital of A Coruña, A Coruña, Spain., García Gómez J; University Hospital of Ourense, Ourense, Spain.
Source: Cancer medicine [Cancer Med] 2019 Mar; Vol. 8 (3), pp. 882-889. Date of Electronic Publication: 2019 Jan 28.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-7634
DOI:10.1002/cam4.1903